0000950134-05-017107 Sample Contracts

LEASE
Lease • September 2nd, 2005 • SGX Pharmaceuticals, Inc. • California
UNDERWRITING AGREEMENT
Underwriting Agreement • September 2nd, 2005 • SGX Pharmaceuticals, Inc. • New York
1. PURPOSE
Memorandum of Understanding • September 2nd, 2005 • SGX Pharmaceuticals, Inc.
STRUCTURAL GENOMIX, INC.
Investor Rights Agreement • September 2nd, 2005 • SGX Pharmaceuticals, Inc. • California
BACKGROUND
Collaboration Agreement • September 2nd, 2005 • SGX Pharmaceuticals, Inc. • Delaware
RECITALS
Amendment to Agreement • September 2nd, 2005 • SGX Pharmaceuticals, Inc.
Exhibit 10.31 MASTER LOAN AND SECURITY AGREEMENT NO. 2081008 DATED: AUGUST 28, 2002
Master Loan and Security Agreement • September 2nd, 2005 • SGX Pharmaceuticals, Inc.
BACKGROUND
Collaboration and License Agreement • September 2nd, 2005 • SGX Pharmaceuticals, Inc. • Delaware
RECITALS
Indemnification Agreement • September 2nd, 2005 • SGX Pharmaceuticals, Inc. • Delaware
BACKGROUND
Collaboration Agreement • September 2nd, 2005 • SGX Pharmaceuticals, Inc. • Delaware
23 JULY 2004
Patent and Know How License • September 2nd, 2005 • SGX Pharmaceuticals, Inc. • Georgia
RECITALS
Drug Discovery Agreement • September 2nd, 2005 • SGX Pharmaceuticals, Inc. • Maryland
OSI Pharmaceuticals, Inc. 58 South Service Road, Suite 110 Melville, NY 11747 T 631.962.2000 F 631.752.3880 www.osip.com [(OSI)(TM) PHARMACEUTICALS LOGO)] January 11, 2004 VIA FEDERAL EXPRESS Sean A. McCarthy, D.Phil. Vice President, Business...
Collaboration Agreement • September 2nd, 2005 • SGX Pharmaceuticals, Inc.

This letter confirms acceptance by Structural GenomiX of an amendment to Section 2.8(b) of the above-referenced Collaboration Agreement whereby effective immediately, OSI Pharmaceuticals shall have the option to increase its membership on the Joint Steering Committee (JSC) to three (3) representatives, one of whom shall be a non-voting representative.